ZYGLPIA Trademark

Trademark Overview


On Friday, June 10, 2022, a trademark application was filed for ZYGLPIA with the United States Patent and Trademark Office. The USPTO has given the ZYGLPIA trademark a serial number of 97452965. The federal status of this trademark filing is THIRD EXTENSION - GRANTED as of Monday, October 28, 2024. This trademark is owned by Zydus Pharmaceuticals (USA) Inc.. The ZYGLPIA trademark is filed in the Pharmaceutical Products category with the following description:

Anti-inflammatories; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; Pharmaceutical preparations for the treatment and prevention of hematalogic disorders and for use in tissue and organ transplantation; Pharmaceutical preparations fo...
zyglpia

General Information


Serial Number97452965
Word MarkZYGLPIA
Filing DateFriday, June 10, 2022
Status732 - THIRD EXTENSION - GRANTED
Status DateMonday, October 28, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 4, 2023

Trademark Statements


Goods and ServicesAnti-inflammatories; Antibacterial pharmaceuticals; Cardiovascular pharmaceuticals; Inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; Pharmaceutical preparations acting on the central nervous system; Pharmaceutical preparations and substances for the treatment of gastro-intestinal diseases; Pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, for the treatment of bacteria-based diseases, and for the treatment of diabetes, and anti - infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; Pharmaceutical preparations for the treatment and prevention of diseases and disorders of the autoimmune system, the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; Pharmaceutical preparations for the treatment and prevention of hematalogic disorders and for use in tissue and organ transplantation; Pharmaceutical preparations for the treatment and prevention of eye diseases and conditions; Pharmaceutical preparations for the treatment and prevention of heart rhythm disorders; Pharmaceutical preparations for the treatment and prevention of immune system related diseases and disorders; Pharmaceutical preparations for the treatment and prevention of kidney diseases; Pharmaceutical preparations for the treatment and prevention of hypertension; Pharmaceutical preparations for the treatment and prevention of skin disorders; Pharmaceutical preparations for the treatment and prevention of cancer and tumors; Pharmaceutical preparations for the treatment and prevention of allergies; Pharmaceutical preparations for the treatment and prevention of bone diseases; Pharmaceutical preparations for the treatment and prevention of respiratory diseases and asthma; Pharmaceutical preparations for use in dermatology; Pharmaceutical preparations for use in urology; Pharmaceutical products for ophthalmological use

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, February 16, 2023
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameZydus Pharmaceuticals (USA) Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressPennington, NJ 08534

Party NameZydus Pharmaceuticals (USA) Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressPennington, NJ 08534

Trademark Events


Event DateEvent Description
Tuesday, June 14, 2022NEW APPLICATION ENTERED
Tuesday, June 14, 2022NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, February 15, 2023ASSIGNED TO EXAMINER
Thursday, February 16, 2023EXAMINERS AMENDMENT -WRITTEN
Thursday, February 16, 2023EXAMINERS AMENDMENT E-MAILED
Thursday, February 16, 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Thursday, February 16, 2023EXAMINER'S AMENDMENT ENTERED
Friday, February 24, 2023APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 15, 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 4, 2023PUBLISHED FOR OPPOSITION
Tuesday, April 4, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 30, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, October 19, 2023SOU TEAS EXTENSION RECEIVED
Thursday, October 19, 2023SOU EXTENSION 1 FILED
Thursday, October 19, 2023SOU EXTENSION 1 GRANTED
Saturday, October 21, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 11, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Thursday, April 11, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, April 11, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, April 11, 2024TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Tuesday, April 16, 2024SOU TEAS EXTENSION RECEIVED
Tuesday, April 16, 2024SOU EXTENSION 2 FILED
Tuesday, April 16, 2024SOU EXTENSION 2 GRANTED
Wednesday, April 17, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 28, 2024SOU TEAS EXTENSION RECEIVED
Monday, October 28, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 28, 2024SOU EXTENSION 3 GRANTED
Monday, October 28, 2024SOU EXTENSION 3 FILED